These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 22076492)

  • 1. Current treatment options for neuroendocrine tumors.
    Hörsch D; Grabowski P; Schneider CP; Petrovitch A; Kaemmerer D; Hommann M; Baum RP
    Drugs Today (Barc); 2011 Oct; 47(10):773-86. PubMed ID: 22076492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic Therapies for Advanced Pancreatic Neuroendocrine Tumors.
    Raj N; Reidy-Lagunes D
    Hematol Oncol Clin North Am; 2016 Feb; 30(1):119-33. PubMed ID: 26614372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacologic therapy for neuroendocrine tumours].
    Petrányi A; Bodoky G
    Orv Hetil; 2011 Mar; 152(10):379-91. PubMed ID: 21354954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic Therapies for Advanced Gastrointestinal Carcinoid Tumors.
    Mulvey CK; Bergsland EK
    Hematol Oncol Clin North Am; 2016 Feb; 30(1):63-82. PubMed ID: 26614369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic neuroendocrine neoplasms.
    Hörsch D; Bert T; Schrader J; Hommann M; Kaemmerer D; Petrovitch A; Zaknun J; Baum RP
    Minerva Gastroenterol Dietol; 2012 Dec; 58(4):401-26. PubMed ID: 23207615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic strategies for advanced neuroendocrine carcinomas of jejunum/ileum and pancreatic origin.
    Auernhammer CJ; Göke B
    Gut; 2011 Jul; 60(7):1009-21. PubMed ID: 21378384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic strategies for neuroendocrine liver metastases.
    Frilling A; Clift AK
    Cancer; 2015 Apr; 121(8):1172-86. PubMed ID: 25274401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolving treatment strategies for management of carcinoid tumors.
    Strosberg J
    Curr Treat Options Oncol; 2013 Sep; 14(3):374-88. PubMed ID: 23892588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Digestive neuroendocrine tumors (DNET): the era of targeted therapies.
    Boussaha T; Rougier P; Taieb J; Lepere C
    Clin Res Hepatol Gastroenterol; 2013 Apr; 37(2):134-41. PubMed ID: 23562338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current clinical trials of targeted agents for well-differentiated neuroendocrine tumors.
    Raj N; Reidy-Lagunes D
    Pancreas; 2014 Nov; 43(8):1185-9. PubMed ID: 25333401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic neuroendocrine tumors.
    Muniraj T; Vignesh S; Shetty S; Thiruvengadam S; Aslanian HR
    Dis Mon; 2013 Jan; 59(1):5-19. PubMed ID: 23312533
    [No Abstract]   [Full Text] [Related]  

  • 12. Advances in the systemic treatment of neuroendocrine tumors in the era of molecular therapy.
    Leung R; Lang B; Wong H; Chiu J; Yat WK; Shek T; Cho WY; Yau LC; Yau T
    Anticancer Agents Med Chem; 2013 Mar; 13(3):382-8. PubMed ID: 23092266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic neuroendocrine tumors: targeting the molecular basis of disease.
    Khagi S; Saif MW
    Curr Opin Oncol; 2015 Jan; 27(1):38-43. PubMed ID: 25390554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current status and perspectives of targeted therapy in well-differentiated neuroendocrine tumors.
    Naraev BG; Strosberg JR; Halfdanarson TR
    Oncology; 2012; 83(3):117-27. PubMed ID: 22797357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pulmonary neuroendocrine neoplasms].
    Sayeg Y; Sayeg M; Baum RP; Kulkarni HR; Presselt N; Mäder I; Kunze A; Sänger J; Hörsch D; Bonnet R
    Pneumologie; 2014 Jul; 68(7):456-77. PubMed ID: 25006841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evolving landscape of neuroendocrine tumors.
    Bergsland EK
    Semin Oncol; 2013 Feb; 40(1):4-22. PubMed ID: 23391109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of somatostatins in gastroenteropancreatic neuroendocrine tumor development and therapy.
    Oberg KE; Reubi JC; Kwekkeboom DJ; Krenning EP
    Gastroenterology; 2010 Sep; 139(3):742-53, 753.e1. PubMed ID: 20637207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Gastrointestinal neuroendocrine tumors: update 2024].
    Lahner H; Pavel M
    Inn Med (Heidelb); 2024 Jul; 65(7):664-671. PubMed ID: 38900278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor imaging and therapy using radiolabeled somatostatin analogues.
    de Jong M; Breeman WA; Kwekkeboom DJ; Valkema R; Krenning EP
    Acc Chem Res; 2009 Jul; 42(7):873-80. PubMed ID: 19445476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PI3K-AKT-mTOR-signaling and beyond: the complex network in gastroenteropancreatic neuroendocrine neoplasms.
    Briest F; Grabowski P
    Theranostics; 2014; 4(4):336-65. PubMed ID: 24578720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.